Speakers

Avencia Sanchez-Mejias

Co-Founder and Chief Executive Officer • Integra Therapeutics

Avencia has a PhD in Molecular Biology and a Master’s in Biomedical Research from the University of Seville. Avencia has had a solid career in clinical genetics, molecular oncology and synthetic biology at research centres tied to university hospitals in several countries, including Spain, the United States and Singapore.

Avencia did her post-doc at the National University of Singapore and the University of Miami Miller School of Medicine. In 2018, she joined the Translational Synthetic Biology Lab at Pompeu Fabra University, led by Dr Marc Güell.

In recent years, Avencia has focused on transferring the knowledge generated in these institutions to society through her entrepreneurial project, Integra Tx. Founded with Dr Marc Güell, Integra Tx is a Barcelona-based company that is creating the latest-generation gene-editing tools to make advanced therapies safer and more effective.

Avencia is committed to helping develop female talent and encouraging coming generations to go into STEM fields. In 2021, she was chosen to take part in the Academy for Women Entrepreneurs programme promoted by Foment del Treball and the US Consulate in Barcelona.

Also speaking

Jacqueline Barry

Chief Clinical Officer • CGT Catapult

Antonin de Fougerolles

Chief Executive Officer • Evox Therapeutics

Rafiq Hasan

Chief Executive Officer • Complement Therapeutics

Event Info

Image

Sponsorship Opportunities Waiting List

Take a look at the sample attendee list for Advanced Therapies Europe 2023 here.
Image

Partnering

Find out more about partnering at Advanced Therapies Europe.